Neddylation of HER2 Inhibits its Protein Degradation and promotes Breast Cancer Progression
International Journal of Biological Sciences · 2023
DOI: 10.7150/ijbs.75852 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Biological Sciences, 2023. Verfasst von Xiaohong Xia und 9 weiteren Autor:innen. Beteiligte Einrichtung: Affiliated Cancer Hospital & Institute of Guangzhou Medical University, Guangzhou 510095, China. Hauptthemen laut MEDLINE: Breast Neoplasms, Proteolysis, Erb-b2 Receptor Tyrosine Kinases, Ubiquitination. Die Arbeit wurde bisher 22-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
HER2 is a transmembrane receptor with intrinsic tyrosine kinase activity that is overexpressed in almost 25% of human breast cancers. Here, we report that the neddylation of HER2 is a new post-translational modification that controls its expression and oncogenic activity in human breast cancer. Two critical members in the neddylation pathway, NEDD8 and NEDD8-activating enzyme E1 subunit 1 (NAE1), are detected in human breast specimens. Overexpressed NEDD8 and NAE1 are positively correlated with HER2 expression in human breast cancer. Subsequent structure and function experiments show that HER2 directly interacts with NEDD8 and NAE1, whereas HER2 protein expression is decreased by neddylation depletion. Mechanistically, neddylation inhibition promotes the degradation of HER2 protein by improving its ubiquitination. HER2 overexpression abrogates neddylation depletion-triggered cell growth suppression. The inhibition of neddylation synergized with trastuzumab significantly suppresses growth of HER2 positive breast cancer. Collectively, this study demonstrates a previously undiscovered role of NEDD8-dependent HER2 neddylation promotes tumor growth in breast cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Affiliated Cancer Hospital & Institute of Guangzhou Medical University, Guangzhou 510095, China.
- Guangzhou Municipal and Guangdong Provincial Key Laboratory of Protein Modification and Degradation, School of Basic Medical Sciences, Guangzhou Medical University, Guangzhou 511436, China.
- Department of Surgery, UT Southwestern Medical Center, Dallas, Texas 75390, USA.
Zitieren
APA
Xia, X., Hu, T., He, X., Liu, Y., Yu, C., Kong, W., Liao, Y., Tang, D., Liu, J., & Huang, H. (2023). Neddylation of HER2 Inhibits its Protein Degradation and promotes Breast Cancer Progression. International Journal of Biological Sciences. https://doi.org/10.7150/ijbs.75852
Vancouver
Xia X, Hu T, He X, Liu Y, Yu C, Kong W, et al. Neddylation of HER2 Inhibits its Protein Degradation and promotes Breast Cancer Progression. International Journal of Biological Sciences. 2023. doi:10.7150/ijbs.75852
BibTeX
@article{Xia2023,
author = {Xia, Xiaohong and Hu, Tumei and He, Xiaoyue and Liu, Yuan and Yu, Cuifu and Kong, Weiyao and Liao, Yuning and Tang, Daolin and Liu, Jinbao and Huang, Hongbiao},
title = {Neddylation of HER2 Inhibits its Protein Degradation and promotes Breast Cancer Progression},
journal = {International Journal of Biological Sciences},
year = {2023},
doi = {10.7150/ijbs.75852}
}
EUVIMED